Am. J. Respir. Cell Mol. Biol.,
Volume 18, Number 2, February, 1998 286-293
CD49d Expression and Function on Allergen-stimulated T Cells from
Blood and Airway
Karin A.
Pacheco,
Maciej
Tarkowski,
Julie
Klemm,
and
Lanny J.
Rosenwasser
Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado
The
4 chain (CD49d), which constitutes one of the chains of
4
1 (very late activating antigen-4 [VLA-4])
and
4
7 integrins, mediates migration of T cells to extravascular spaces. The interaction between VLA-4
and vascular cell adhesion molecule-1 (VCAM-1) has been shown to be the critical pathway for the selective accumulation of eosinophils and basophils at sites of allergic inflammation. T lymphocytes are also
specifically recruited into allergic sites, including the allergic asthmatic airway. Increased numbers of activated CD4+ cells expressing the DR antigen subset of the human leukocyte antigens (HLA-DR) appear in
the allergic lung 48 h after allergen inhalation. The mechanisms by which these cells localize into the lung
are still unknown. We report that stimulation of allergen-specific T cells with allergen in vitro resulted in
enhanced expression of
4 chain (CD49d) as measured by receptor density on allergen-specific T-cell lines
and T-cell clones. Kinetic studies showed that CD49d density was enhanced over a 24- to 48-h period in a
time-dependent fashion, and was coordinately upregulated with HLA-DR expression. We also demonstrated that increased expression of CD49d on T-cell lines 24 h and 48 h after stimulation correlated with
increased adhesion to the CS-1 fragment of fibronectin. In contrast, lymphocyte function-associated antigen-1b (LFA-1b) (CD11b), LFA-3 (CD58), and intercellular adhesion molecule-1 (ICAM-1) (CD54) expression did not change with allergen stimulation. We also showed that CD49d receptor density on T cells
obtained by bronchoalveolar lavage (BAL) of allergic patients before and 48 h after allergen challenge was
significantly higher than that on T cells taken from BAL of normal subjects and from controls with other
inflammatory lung diseases. Taken together, these findings indicate that allergen stimulation activates allergen-specific T cells and coordinately induces increased CD49d receptor expression and binding to
counterligands. We postulate that allergen-driven upregulation of CD49d, which together with the
1
chain constitutes VLA-4 integrin, may be responsible for the selective accumulation of T cells in the allergic asthmatic lung.